Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC9 | O60706 | 9/20 | 0.42 |
| ▸ | KCNJ11 | Q14654 | 9/20 | 0.42 |
| ▸ | ABCC8 | Q09428 | 7/20 | 0.42 |
| ▸ | KCNJ8 | Q15842 | 7/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | EED | O75530 | 3/20 | 0.33 |
| ▸ | SUZ12 | Q15022 | 3/20 | 0.33 |
| ▸ | EZH2 | Q15910 | 3/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.30 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.30 |
| ▸ | IL1RN | P18510 | 1/20 | 0.30 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.30 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL855174 | 0.82 | ABCC9 (0.39) | ABCC9KCNJ11ABCC8KCNJ8 | |
| SCHEMBL33526483 | 0.76 | MAOA (0.38) | ABCC9KCNJ11ABCC8KCNJ8MAOA | |
| SCHEMBL12261417 | 0.74 | KDM4E (0.56) | ABCC9KCNJ11ABCC8KCNJ8KDM4E | |
| SCHEMBL14720202 | 0.72 | ABCC9 (0.36) | ABCC9KCNJ11ABCC8KCNJ8MAOA | |
| SCHEMBL12565316 | 0.72 | LMNA (0.42) | ABCC9KCNJ11ABCC8KCNJ8MAOA | |
| SCHEMBL18797086 | 0.71 | ABCC9 (0.33) | ABCC9KCNJ11ABCC8KCNJ8PARP1 | |
| SCHEMBL854104 | 0.70 | ALOX5 (0.38) | ABCC9KCNJ11ABCC8KCNJ8MAOA | |
| SCHEMBL17128311 | 0.69 | PARP10 (0.51) | ABCC9KCNJ11ABCC8KCNJ8MAOA | |
| SCHEMBL21752292 | 0.69 | LMNA (0.39) | ABCC9KCNJ11ABCC8KCNJ8MAOA | |
| SCHEMBL33526277 | 0.67 | MAOA (0.36) | MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | ABCC9 1207/4885KCNJ11 901/4885ABCC8 968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.